-
Recent advances that provide effective treatment of newly diagnosed disease have markedly improved the morbidity of what used to be a devastating disease leading to deformity and disability.
-
The BinaxNOW® Malaria test, a 15-minute immunochromatographic test with a high sensitivity for the diagnosis of malaria due to Plasmodium falciparum has been approved for use by the FDA.
-
In this study of 51 adult ICUs, units with higher nurse staffing had a lower incidence of central line-associated bloodstream infections, ventilator-associated pneumonia, and decubiti.
-
Daily use of SSRIs is associated with a 2-fold increase in the risk of fractures.
-
Asymptomatic individuals with systolic left ventricular (LV) dysfunction have an increased mortality. Angiotensin converting enzymes inhibitors (ACEI) and angiotensin receptor blockers (ARB) favorably affect such patients, but little is known abut the effect of beta-blockers in this group.
-
Older women taking SSRIs had higher rates of hip bone loss compared to both nonusers and TCA users, when measured twice over an average of 5 years.
-
Treatment of the first episode of pyelonephritis in children with oral antibiotics alone for 10 days is not inferior to parenteral therapy for 3 days followed by oral therapy for 7 days.
-
-
Mupirocin Less Effective Against MRSA; New Guideline for Asthma Diagnosis/Management; FDA Actions
-
CA-125 measurements alone or as part of a multimodal strategy are routinely used clinically to aid in developing a treatment plan for women with adnexal masses.